{"nct_id":"NCT01908413","title":"Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-427 When Given to Patients With Advanced and Refractory Solid Tumors or Lymphoma","status":"TERMINATED","status_verified_date":"2016-11","start_date":"2013-07","start_date_type":null,"primary_completion_date":"2015-03","primary_completion_date_type":"ACTUAL","completion_date":"2015-11","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["CRIS"]}